Solid Biosciences is trading 6.91% down at $9.05 after its $9.72 close on August 26, 2026; no new company-specific announcement, earnings release, regulatory decision, or analyst downgrade was identified overnight.
- Latest company disclosure remains its August 6 second-quarter update.
- The S&P 500 is up 0.39% and Nasdaq Composite 1.02% pre-market, so the decline does not appear driven by broad risk-off sentiment.
- The move remains unexplained and may reflect trading-specific volatility or delayed reaction to prior financing concerns.